{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:02:17Z","timestamp":1790935337048,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The prognosis for T2N0 glottic squamous cell carcinoma (SCC) is generally favorable, with a 5-year overall survival rate of 79%\u201396% achieved with radiotherapy (RT), the standard nonsurgical treatment for this condition. However, the local control rate for T2N0 glottic SCC treated with RT remains suboptimal, with a 5-year local control rate of only 65%\u201380%. Local residual disease or recurrence following RT for T2N0 glottic SCC often leads to difficulties in laryngeal preservation. When total laryngectomy is performed as a salvage surgery in such cases, patients lose their physiological ability to speak. Therefore, improving local control and laryngeal preservation rates through RT could substantially improve the quality of life of these patients. Attempts have been made to combine cytotoxic anticancer agents with RT to achieve better local control in patients with T2N0 glottic SCC. In Japan, several studies have evaluated the effects of combining S-1, an oral fluorinated pyrimidine, with RT in these patients. This review highlights the importance of adding chemotherapy to RT in the treatment of patients with T2N0 glottic SCC.<\/jats:p>","DOI":"10.1093\/jjco\/hyaf014","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T16:40:46Z","timestamp":1737909646000},"page":"459-464","source":"Crossref","is-referenced-by-count":1,"title":["Significance of adding chemotherapy to radiotherapy in the treatment of T2N0 glottic cancer"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-4724","authenticated-orcid":false,"given":"Daisuke","family":"Sano","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, School of Medicine , Yokohama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, School of Medicine , Yokohama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"2025042804261046400_ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025042804261046400_ref2","author":"Report of Head and Neck Cancer Registry of Japan FIve-year Prognosis of Patients Registered in 2016","year":"2024"},{"key":"2025042804261046400_ref3","volume-title":"Clinical practice guidelines In oncology head and neck cancers version 3.2024","author":"National Comprehensive Cancer Network","year":"2024"},{"key":"2025042804261046400_ref4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00405-012-1947-1","article-title":"Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma","volume":"269","author":"Gogh","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025042804261046400_ref5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/cncr.20181","article-title":"Management of T1-T2 glottic carcinomas","volume":"100","author":"Mendenhall","year":"2004","journal-title":"Cancer"},{"key":"2025042804261046400_ref6","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/hed.21528","article-title":"Evidence-based review of treatment options for patients with glottic cancer","volume":"33","author":"Hartl","year":"2011","journal-title":"Head Neck"},{"key":"2025042804261046400_ref7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/coa.12139","article-title":"Radiotherapy for T1-2N0 glottic cancer: A multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients","volume":"38","author":"Al-Mamgani","year":"2013","journal-title":"Clin Otolaryngol"},{"key":"2025042804261046400_ref8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1288\/00005537-199008000-00013","article-title":"The predictive value of tumor classification compared with results of the British Institute of Radiology fractionation trial in the treatment of laryngopharyngeal carcinoma","volume":"100","author":"Wiernik","year":"1990","journal-title":"Laryngoscope"},{"key":"2025042804261046400_ref9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy","volume":"78","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025042804261046400_ref10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1748-717X-7-193","article-title":"Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: A 20 year Cleveland Clinic experience","volume":"7","author":"Khan","year":"2012","journal-title":"Radiat Oncol"},{"key":"2025042804261046400_ref11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.oraloncology.2016.10.013","article-title":"Risk factors for radiation failure in early-stage glottic carcinoma: A systematic review and meta-analysis","volume":"62","author":"Eskiizmir","year":"2016","journal-title":"Oral Oncol"},{"key":"2025042804261046400_ref12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000108385","article-title":"A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma","volume":"71","author":"Tsuji","year":"2006","journal-title":"Oncology"},{"key":"2025042804261046400_ref13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ijrobp.2005.10.003","article-title":"Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control","volume":"64","author":"Akimoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025042804261046400_ref14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1017\/S0022215106000880","article-title":"Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx","volume":"120","author":"Taguchi","year":"2006","journal-title":"J Laryngol Otol"},{"key":"2025042804261046400_ref15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11604-005-1517-1","article-title":"Retrospective analysis: Concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer","volume":"24","author":"Itoh","year":"2006","journal-title":"Radiat Med"},{"key":"2025042804261046400_ref16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1758-3284-2-20","article-title":"Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: Retrospective analysis","volume":"2","author":"Hirasawa","year":"2010","journal-title":"Head Neck Oncol"},{"key":"2025042804261046400_ref17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/jjco\/hyq077","article-title":"Phase I\/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer","volume":"40","author":"Nakayama","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"2025042804261046400_ref18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1269\/jrr.09134","article-title":"Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma","volume":"51","author":"Nonoshita","year":"2010","journal-title":"J Radiat Res"},{"key":"2025042804261046400_ref19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/00016489.2012.691212","article-title":"Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx who received concurrent chemoradiation therapy with carboplatin (CBDCA) - AUC 1.5 vs AUC 2.0","volume":"132","author":"Furusaka","year":"2012","journal-title":"Acta Otolaryngol"},{"key":"2025042804261046400_ref20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.anl.2014.02.001","article-title":"Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: A retrospective comparative study","volume":"41","author":"Higashino","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"2025042804261046400_ref21","first-page":"2385","article-title":"Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma","volume":"35","author":"Kimura","year":"2015","journal-title":"Anticancer Res"},{"key":"2025042804261046400_ref22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.oraloncology.2017.05.017","article-title":"Impact of combined modality treatment with radiotherapy and S-1 on T2N0 laryngeal cancer: Possible improvement in survival through the prevention of second primary cancer and distant metastasis","volume":"71","author":"Kitani","year":"2017","journal-title":"Oral Oncol"},{"key":"2025042804261046400_ref23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13014-016-0741-4","article-title":"Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer","volume":"12","author":"Saitoh","year":"2017","journal-title":"Radiat Oncol"},{"key":"2025042804261046400_ref24","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s10147-020-01705-x","article-title":"Chemoradiotherapy for high-risk stage II laryngeal cancer","volume":"25","author":"Hamauchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"2025042804261046400_ref25","doi-asserted-by":"publisher","first-page":"104454","DOI":"10.1016\/j.oraloncology.2019.104454","article-title":"Addition of S-1 to radiotherapy for treatment of T2N0 glottic cancer: Results of the multiple-center retrospective cohort study in Japan with a propensity score analysis","volume":"99","author":"Sano","year":"2019","journal-title":"Oral Oncol"},{"key":"2025042804261046400_ref26","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/1078-0432.CCR-06-0747","article-title":"Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians","volume":"12","author":"Mattison","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2025042804261046400_ref27","doi-asserted-by":"publisher","first-page":"106942","DOI":"10.1016\/j.oraloncology.2024.106942","article-title":"Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the head and neck cancer registry of Japan","volume":"157","author":"Ichisaka","year":"2024","journal-title":"Oral Oncol"},{"key":"2025042804261046400_ref28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00016480701200251","article-title":"Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN)","volume":"127","author":"Katori","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"2025042804261046400_ref29","first-page":"661","article-title":"Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation","volume":"29","author":"Nishimura","year":"2009","journal-title":"Anticancer Res"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/5\/459\/61627148\/hyaf014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/5\/459\/61627148\/hyaf014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:26:20Z","timestamp":1745828780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/5\/459\/7979334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,1,26]]},"published-print":{"date-parts":[[2025,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf014","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,1,26]]}}}